Sutherland G R, Baker E, Hyland V J, Callen D F, Stahl J, Gough N M
Department of Histopathology, Adelaide Children's Hospital, Australia.
Leukemia. 1989 Jan;3(1):9-13.
The gene for human leukemia inhibitory factor (LIF) has been mapped by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of two normal males and some individuals with chromosomal rearrangements. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. From the grain distribution over high resolution chromosome preparations, the most likely location is 22q12.1----q12.2. Southern analysis of DNA from one Ewing sarcoma with t[11;22][q24;q12] showed that the breakpoint on chromosome 22 is more than 15 kb 5' or 8 kb 3' from the LIF gene. The location of the LIF gene indicates that translocations of this gene are unlikely to play a role in myeloid leukemia and myeloproliferative disorders.
通过对一系列小鼠/人类体细胞杂种进行Southern分析,并对两名正常男性及一些患有染色体重排的个体的染色体进行原位杂交,已对人类白血病抑制因子(LIF)基因进行了定位。该基因定位于22q11 - q12.2,位于费城染色体易位BCR基因与细胞系GM2324中22q12.2处易位的断点之间。从高分辨率染色体标本上的银粒分布来看,最可能的位置是22q12.1----q12.2。对一例患有t[11;22][q24;q12]的尤因肉瘤的DNA进行Southern分析表明,22号染色体上的断点距离LIF基因在5'端超过15 kb或在3'端超过8 kb。LIF基因的定位表明,该基因的易位不太可能在髓系白血病和骨髓增殖性疾病中起作用。